Figure 4
From: Bone marrow-derived progenitor cells in end-stage lung disease patients
Lung function and progenitor cell profiles. No correlation in Cystic Fibrosis (CF) patients between FEV1/FVC and (A) Clara Cell Secretory Protein (CCSP+) bone marrow cells (BMCs) (n = 27), (B) CCSP + peripheral blood mononuclear cells (PBMCs) (n = 32), or (C) CD45 + Collagen-1+ fibrocytes (n = 14). No correlation in Chronic Obstructive Pulmonary Disease (COPD) patients between FEV1/FVC and (D) CCSP + BMCs (n = 34), (E) CCSP + PBMCs (n = 40), or (F) CD45 + Collagen-1+ fibrocytes (n = 22). No correlation in Pulmonary Fibrosis (PF) patients between the measured percentage of predicted of FVC and (G) CCSP + BMCs (n = 41), (H) CCSP + PBMCs (n = 53), or (I) CD45 + Collagen-1+ fibrocytes (n = 26). Spearman rank test.